DAVID FOSTER: Open Payments
NPI 1285695957 · ALBANY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,890 in 74 payments from 18 companies in 2025. Trend: 2023 $1,793 · 2024 $2,032 · 2025 $1,890
Food & beverage: $1,514Education: $376
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $454 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 10 | $280 |
| Galderma Laboratories, L.P. | 9 | $197 |
| Glaukos Corporation | 1 | $143 |
| Regeneron Healthcare Solutions, Inc. | 9 | $141 |
| Alcon Vision LLC | 1 | $135 |
| Janssen Biotech, Inc. | 1 | $100 |
| SANOFI-AVENTIS U.S. LLC | 1 | $89 |
| Novartis Pharmaceuticals Corporation | 4 | $70 |
| GENZYME CORPORATION | 2 | $55 |
Products named: SKYRIZI, DUPIXENT, NEMLUVIO, iDoseTR, Rocklatan, TREMFYA, ILUMYA, RINVOQ.
Industry payments across NY — which companies pay providers there.
